Perspectives in Medical Research

Volume: 9 Issue: 3

  • Open Access
  • Original Article

Non-Invasive Assessment Of Liver Fibrosis In Patients With Non-Alcoholic Fatty Liver Disease In A Tertiary Care Hospital

1 Assistant professor, Department of General Medicine, Government Medical College & Hospital, Thiruvallur
Senior Resident,Department of General Medicine, Government Medical College & Hospital, Thiruvallur
*Corresponding Author: Anandaraj Jayaraman, Assistant professor, Department of General Medicine, Government Medical College & Hospital, Thiruvallur
E-MAIL: [email protected]

Year: 2021, Page: 64-67, Doi: https://doi.org/10.47799/pimr.0903.15

Received: Oct. 28, 2021 Accepted: Dec. 6, 2021 Published: Dec. 6, 2021

Abstract

Aims: To compare the NAFLD fibrosis score and FIBROSIS 4 score to fibroscan, and affirm whether the scores shall be used as a screening tool for liver fibrosis, in place of fibroscan. Methodology: It was a cross-sectional study. Patients with fatty liver on ultrasonological examination with 200 sample size. After obtaining the informed consent the following details were collected socio-demographic details, history, co-morbidities, anthropometric measurements, Laboratory investigations. Results: the ROC curve analysis of fibroscan reveals the area under curve of 0.499 and based on the cut off value of 4.50Kpas the sensitivity and specificity was found to be 85.7% and 83.5% respectively. The ROC curve analysis of fibrosis-4 reveals the area under curve of 0.495 and based on the cut off value of 0.80 the sensitivity and specificity was found to be 91.9% and 92.1% respectively. Analysis of NAFLD fibrosis score reveals the area under curve of 0.476 and based on the cut off value of -1.53 the sensitivity and specificity was found to be 93.1% and 93.9% respectively. Conclusion: Henceforth the study suggests that NAFLD fibrosis score shall be used as a non -invasive bedside assessment of liver fibrosis in high risk population and hence guiding their follow up for prevention of morbidity in resource limited settings.

Keywords: NAFLD, fibrosis, fibroscan 3

References

  1. Schaffner, F & Thaler, H . 1986. Non alcoholic fatty liver disease. Prog liver 8:283–98.

  2. Merat, S, Yarahmadi, S & Tahaghoghi, S . 2009. Prevalence of Fatty Liver Disease among Type 2 Diabetes Mellitus Patients and its Relation to Insulin Resistance. Middle East Journal of Digestive Diseases 1(2):74–79.

  3. Ludwig, Y, Viggiano, T R, Mcgill, D B & Bj, Ctt . 1980. (Vol. 55, pp. 434-438) Non alcoholic steatohepatitis: Mayo Clin Proc

  4. Fallatah, H I . 2014. Noninvasive Biomarkers of Liver Fibrosis: An Overview. Advances in Hepatology 15–17.

  5. Machado, M V & Cortez-Pinto, H . 2013. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J Hepatol 58(5):1007–1008.

  6. Anastasiouo, E, Büchter, M, Baba, H, Korth, J, Canbay, A, Gerken, G & Kahraman, A . 2016. Performance and utility of transient elastography and non-invasive markers of liver fibrosis in patients with autoimmune hepatitis: a single centre experience. Hepat Mon 1.

  7. Tuong, T T & Duc, N M . 2018. The Role Of Non-Invasive Methods In Evaluating Liver Fibrosis Of Patients With Non-Alcoholic Steatohepatitis. Imaging in Medicine 10(6):159–63.

Cite this article

Ramadoss I, Jayaraman A, Dhanapal S. Non-Invasive Assessment Of Liver Fibrosis In Patients With Non-Alcoholic Fatty Liver Disease In A Tertiary Care Hospital. Perspectives in Medical Research. 2021;9(3):64-67 DOI: 10.47799/pimr.0903.15

Views
27
Downloads
9
Citations